Mutations Position Table
PSEN1 P267 Mutations
| Mutation | Clinical Phenotype |
Pathogenicity | Neuropathology | Biological Effect | Genomic Position | Coding/Non-Coding | Genomic Region | Mutation Type Codon Change |
Research Models |
Primary Papers |
|---|---|---|---|---|---|---|---|---|---|---|
| P267L |
Alzheimer's Disease | AD : Not Classified | Unknown. | Unknown, but predicted damaging by multiple in silico algorithms. | rs63750779 |
Coding | Exon 8 | Point, Missense CCA to CTA |
0 | Kowalska et al., 2003 |
| P267A |
Alzheimer's Disease | AD : Pathogenic | Frequent neuritic plaques, including in the neocortex (Braak stage VI); Severe cerebral amyloid angiopathy. | Decreased Aβ37/Aβ42, increased Aβ42/Aβ40, and increased Aβ43 in cultured cells. | Coding | Exon 8 | Point, Missense CCA to GCA |
0 | Ringman et al., 2016 | |
| P267S |
Alzheimer's Disease | AD : Pathogenic | Neuropathology consistent with Alzheimer's disease. | Reduced γ-secretase activity; Increased cell cycle arrest. | rs63751229 |
Coding | Exon 8 | Point, Missense CCA to TCA |
0 | Alzheimer's Disease Collaborative Group, 1995; Hutton et al., 1996 |
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.